Nonlinear Dynamics Expands Distribution Operation in the Asia Pacific Region
News Oct 30, 2007
Nonlinear Dynamics Ltd has expanded its presence in Asia Pacific through the appointment of a new Distributor Manager and by extending its distributor network. This announcement follows a successful week at the HUPO World Congress in Seoul, Korea where Nonlinear presented their software range, including Progenesis SameSpots v2.0 and Progenesis Stats, for 2D and DIGE image analysis.
Dr. Paul Goulding has been appointed as Distributor Manager and joins Nonlinear after 10 years at UVItec where he gained extensive experience in setting up a distribution network for their gel documentation systems. Paul will be focusing initially on expanding Nonlinear’s distributor network in the Asia Pacific region and developing existing distributor partnerships.
Nonlinear are also delighted to announce the appointment of SCRUM Inc, who specialize in the marketing and sales of scientific products, as their distributors in Japan.
Paul commented, “I am joining Nonlinear at a really exciting time as the SameSpots technology has opened up so many new opportunities for us. The addition of SCRUM Inc to our distributor network is the first part of a strategic plan to expand SameSpots sales in this region. Satoshi Sagara, who has experience of the Nonlinear range from his previous role with PerkinElmer, will be overseeing the promotion of the SameSpots technology at SCRUM and we look forward to capitalizing on his expertise.
“Nonlinear put a very high priority on establishing good relations with their distributors, and this was never more evident than at the HUPO Congress where we worked closely with our Korean distributors, Chayon Laboratories Inc. We recognize the power of having local expertise and support and our association with Chayon is a great example of the kind of distributor relationships we want to build.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019